Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2021

Open Access 01.12.2021 | Research article

Reliability of maternal recall of delivery and immediate newborn care indicators in Sarlahi, Nepal

verfasst von: Emily D. Carter, Karen T. Chang, Luke C. Mullany, Subarna K. Khatry, Steven C. LeClerq, Melinda K. Munos, Joanne Katz

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2021

Abstract

Background

The intrapartum period is a time of high mortality risk for newborns and mothers. Numerous interventions exist to minimize risk during this period. Data on intervention coverage are needed for health system improvement. Maternal report of intrapartum interventions through surveys is the primary source of coverage data, but they may be invalid or unreliable.

Methods

We assessed the reliability of maternal report of delivery and immediate newborn care for a sample of home and health facility births in Sarlahi, Nepal. Mothers were visited as soon as possible following delivery (< 72 h) and asked to report circumstances of labor and delivery. A subset was revisited 1–24 months after delivery and asked to recall interventions received using standard household survey questions. We assessed the reliability of each indicator by comparing what mothers reported immediately after delivery against what they reported at the follow-up survey. We assessed potential variation in reliability of maternal report by characteristics of the mother, birth event, or intervention prevalence.

Results

One thousand five hundred two mother/child pairs were included in the reliability study, with approximately half of births occurring at home. A higher proportion of women who delivered in facilities reported “don’t know” when asked to recall specific interventions both initially and at follow-up. Most indicators had high observed percent agreement, but kappa values were below 0.4, indicating agreement was primarily due to chance. Only “received any injection during delivery” demonstrated high reliability among all births (kappa: 0.737). The reliability of maternal report was typically lower among women who delivered at a facility. There was no difference in reliability based on time since birth of the follow-up interview. We observed over-reporting of interventions at follow-up that were more common in the population and under-reporting of less common interventions.

Conclusions

This study reinforces previous findings that mothers are unable to report reliably on many interventions within the peripartum period. Household surveys which rely on maternal report, therefore, may not be an appropriate method for collecting data on coverage of many interventions during the peripartum period. This is particularly true among facility births, where many interventions may occur without the mother’s full knowledge.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12884-021-03547-5.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CHX
Chlorhexidine
DHS
Demographic and Health Survey
DK
Don’t know
pe
Expected percent agreement
κ
Kappa
MICS
Multiple Indicator Cluster Survey
NNIPS
Nepal Nutrition Intervention Project – Sarlahi
po
Observed percent agreement

Background

The intrapartum and immediate postpartum periods are a time of high mortality risk for newborns and mothers. Neonatal deaths account for almost half of all under-five deaths, and mortality within this period has been difficult to reduce [1]. Numerous interventions exist to minimize risk to both newborns and mothers in the peripartum period. Data on population coverage of these interventions are needed for health programs to ensure that interventions are reaching those in need. However, such data are often scarce or unreliable. Information on the content or quality of care administered during labor and delivery at health facilities is frequently un- or under-documented, and rarely reported in national health information systems. Even less information is available for deliveries occurring outside of the government health system. Population-based surveys of women, with questions focused on care received during recent deliveries, are often used to capture data on intervention coverage for both facility and non-facility deliveries. However, an increasing number of studies have shown that women are often unable to accurately report on the content of care received, particularly for interventions occurring during the peripartum period [26]. A qualitative study by Yoder and colleagues in Bangladesh and Malawi found mothers had difficulty understanding some terminology related to peripartum care and comprehending questions about the timing of events following birth [7]. Work by McCarthy and colleagues suggests that pain, fatigue, and relief of a successful delivery may distract women from noting the care they received [5]. Further, women may not be told about the care they receive, such as the type of injection, or maybe more or less likely to report an intervention due to social desirability biases, sometimes providing responses that are believed to be viewed more positively by others. To date, validation studies of peripartum care have focused on women delivering in health facilities and have primarily been conducted in sub-Saharan Africa or Latin America.
We assessed the reliability of maternal report of delivery care and immediate newborn care for a sample of both home and health facility births in Nepal. Within the first 3 days after delivery, mothers were asked to report on interventions received during the peripartum period. These same women were visited between 1 and 24 months later and asked to recall the interventions they received during the peripartum period. Maternal report at both time points was compared to assess the reliability of maternal recall of peripartum health interventions. We also assessed potential variation in recall reliability by characteristics of the birth, the mother, and intervention prevalence.

Methods

Study setting

The study was conducted in the Sarlahi district of Nepal, bordering the Indian state of Bihar, to the south. Residents are primarily Hindu and agrarian. In the study area, approximately half of births occur at home and half in health facilities.

Parent trial

Data on interventions received during the peripartum period were collected through a parent trial conducted jointly by the Nepal Nutrition Intervention Project – Sarlahi (NNIPS) and our local partner organization, Nepal Netra Jyoti Sangh under the auspices of the Social Welfare Council of the Government of Nepal. Women and their newborns were enrolled in a randomized community-based trial to investigate the impact of full-body newborn massage with sunflower seed oil on newborn deaths and infections. The trial was registered at ClinicalTrials.gov (NCT01177111). The study took place in 34 Village Development Committees in the rural district of Sarlahi, Nepal, between November 2010 and January 2017.
Pregnant women were identified in the community and followed through delivery. Pregnant women participating in the trial were given clean birth kits, chlorhexidine (CHX) for application to the cut umbilical stump, deworming tablets, and counseling on early breastfeeding, thermal care, umbilical cord care, delivery care, postnatal care, and danger signs during labor and postnatal period. Mothers were visited as soon as possible following delivery, typically within 24 h, and asked to report on the date/time of delivery, circumstances of labor and delivery, the health status of the mother and newborn, and baby’s weight. The wording of relevant delivery and immediate postpartum intervention questions administered to the mother at the first visit are listed in Supplementary Questionnaire 1. Additional interviews conducted throughout the first month (days 3, 7, 10, 14, 21, and 28) focused on maternal report and directly observed aspects of newborn health.

Reliability substudy

We randomly selected a subset of mother/child pairs that participated in the parent trial and revisited these women between April and September 2016. Each selected mother was visited at home and asked to report on interventions and events in the peripartum period, including labor and delivery, immediate newborn care, postnatal care, and illness and care within the first 7 days of life using standard questions from the Demographic and Health Survey (DHS) or Multiple Indicator Cluster Survey (MICS) where applicable (see Supplementary Questionnaire 2). Mothers who had a singleton live birth and who were visited at home within 72 h after delivery were eligible. We interviewed approximately equal numbers of mothers at each of seven follow-up time periods: 1, 3, 6, 9, 12, 18, or 24 months after birth (Fig. 1).
Selected mothers were requested to participate in the validation substudy conducted by study staff through an oral consent process in either the Nepali or Maithili language, both of which are spoken in the area. Those who consented to participate were asked to recall care during delivery and the immediate postnatal period prior to discharge.

Ethical approval

The parent trial and validation substudy were approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board in Baltimore, USA. In Nepal, approval was received from the Tribhuvan University Institute of Medicine, Kathmandu (parent trial) and the Nepal Health Research Council, Kathmandu (substudy).

Data analysis

The reliability of each indicator was assessed by comparing what mothers reported immediately after delivery against what was reported at the follow-up survey. We assessed the reliability of 14 indicators, including the use of items within the clean birth kit, injections given during labor / delivery, immediate newborn care, cord care, and early initiation of breastfeeding. Indicators related to immediate newborn care were defined as practices generally occurring between the delivery of the child and the delivery of the placenta. Questions about the application of CHX or other substances to the cord stump were limited to applications immediately following delivery. Early breastfeeding initiation was defined as putting the child to the breast within the first hour after delivery.
For both the initial assessment and follow-up survey, we assessed the proportion of mothers who responded “don’t know” (DK) when asked whether the intervention or practice occurred. Each mother was asked to identify each injection given during labor and delivery. If the mother reported she could not identify a specific injection and did not state oxytocin or ergometrine was given their response on “injectable Oxytocin / Ergometrine given during delivery” was classified as “DK”. The same logic was used for classifying the use of chlorohexidine. Excluding DK responses, we calculated the observed percent agreement, expected percent agreement, and kappa of maternal recall for each indicator. A sensitivity analysis maintaining DK responses as a separate response category was also conducted. The kappa statistic (κ) was used to measure the test-retest reliability of maternal report after excluding agreement due to chance. Chance expected percent agreement (pe) was defined as classification at random assuming probability equal to the overall proportion of yes and no responses at the initial (time 1) and follow-up (time 2) interview. Observed percent agreement (po) was calculated as the number of mothers reporting either receiving or not receiving a specific intervention at both the initial and follow-up survey. The kappa statistic was calculated as the difference in the expected and observed agreement over one minus the expected change agreement (Formula 1).
$$ {p}_e=\left({p}_{y{es}_{t1}}\ast {p}_{y{es}_{t2}}\right)+\left({p}_{no_{t1}}\ast {p}_{no_{t2}}\right) $$
$$ {p}_o={p}_{y{es}_{t1}}\ast \left({p}_{y{es}_{t2}\mid {yes}_{t1}}\right)+{p}_{n{o}_{t1}}\ast \left({p}_{n{o}_{t2}\mid {no}_{t1}}\right) $$
$$ \kappa =\frac{p_o-{p}_e}{1-{p}_e} $$
A κ = 1 is considered perfect agreement and κ = 0 is considered no agreement beyond that expected by chance alone. We interpreted κ values of greater than 0.4 as indicating moderate reliability and values greater than 0.6 as indicating strong reliability. We also calculated the proportion of women who changed their responses from 1) not receiving an intervention at the initial assessment but reported receipt during the follow-up survey (over-report), and 2) reported receiving an intervention at the initial assessment but did not report the intervention during the follow-up survey (under-report). Analyses were stratified by site of delivery, dichotomized as facility deliveries and home deliveries.
At the level of the individual respondent, we assessed potential variation in the reliability of maternal report by characteristics of the mother or birth event we hypothesized could potentially alter women’s ability to recall events around delivery. We used multivariable logistic regression to assess differences in percent agreement, over-reporting, and under-reporting of each indicator by time between birth and follow-up interview (continuous variable), child sex, maternal education (none versus any), maternal age, parity, birth location, and presence of delivery complication. Delivery complications were defined as maternal report of complications during delivery such as excessive bleeding, prolonged labor, convulsions, fever, or obstructed labor at the initial interview. We also looked for unadjusted differences in percent agreement by time since birth using binned categories for the best performing indicators.
We also assessed associations at the indicator level between the reliability of maternal recall and underlying intervention coverage or prevalence, based on initial maternal report. We calculated the unadjusted associations between intervention prevalence and indicator estimates of percent agreement, κ, the proportion of women over-reporting, and the proportion of women under-reporting each indicator. Where significant associations were identified, we calculated the proportion of variability in indicator reliability explained by differences in underlying intervention prevalence. All analyses were conducted in Stata version 14.0 (StataCorp, College Station, TX, USA).

Results

Of the 1892 women selected for the reliability study, 363 were not available, 5 had moved permanently, 3 had died, 4 refused to participate, and 1517 were consented and interviewed (see Supplementary Figure 1). There was no significant difference in the characteristics of those women who were and were not available to participate. After excluding 15 participants (birth assessment > 72 h after birth [n = 3], twin delivery [n = 1], repeat participation due to multiple eligible births [n = 11]), 1502 mother/child pairs were included in the substudy. Of these, 220 were enrolled in the one-month recall group, 207 in the three-month group, 205 in the six-month group, 196 in the nine-month group, 193 in the 12-month group, 284 in the 18-month group, and 197 in the 24-month group (Fig. 1).
More than half of newborns were male (55.5%), and a majority of births occurred in the home (53.8%) (Table 1). The mean recall period was 10.8 months. The mean age of mothers was 23.9 years at the time of delivery. Most mothers had no schooling (68.3%) and had prior children (71.4%). Participants were nearly universally of Madhesi (people of the plains) ethnic origin (96.2%), frequently lacked a household latrine (71.2%), but owned some type of land (97.4%). The substudy sample was comparable to the parent trial sample, but the parent trial sample was more balanced by child sex (male = 51.3%). Stratifying by the site of delivery, women who delivered in health facilities were younger and more educated than women who delivered at home (see Supplementary Table 1). They also were more often having their first child (41.6% vs 17.3%) and more often reported birth complications (28.9% vs 8.7%) compared to women who delivered at home.
Table 1
Characteristics of sample
 
n
Mean / %
95% CI
Recall period (weeks)
1502
47.0
(45.3, 48.8)
Child sex
 Male
834
55.5%
(53.0, 58.0)
 Female
668
44.5%
(42.0, 47.0)
Place of Delivery
 Home
773
53.8%
(51.3, 56.3)
 Facility
728
46.2%
(43.7, 48.7)
Birth complications
 None
1230
82.0%
(80.0, 83.9)
 Reported
270
18.0%
(16.1, 20.0)
Parity
 Primiparous
430
28.6%
(26.3, 30.9)
 Second
382
25.4%
(23.3, 27.7)
 Third
311
20.7%
(18.7, 22.8)
 Fourth +
380
25.3%
(23.2, 27.6)
Maternal Age (yrs) at delivery
  < 20
348
23.2%
(21.2, 25.4)
 20–29
976
65.0%
(62.6, 67.4)
 30–39
162
10.8%
(9.3, 12.5)
 40+
14
0.9%
(0.6, 1.6)
Maternal education
 None
1025
68.3%
(65.9, 70.6)
 Any
476
31.7%
(29.4, 34.1)
Ethnicity
 Madhesi
1444
96.2%
(95.1, 97.1)
 Pahadi
57
3.8%
(2.9, 4.9)
HH electricity
 No electricity
293
19.5%
(17.6, 21.6)
 Had electricity
1208
80.5%
(78.4, 82.4)
HH latrine status
 No latrine
1069
71.2%
(68.8, 73.4)
 Had latrine
432
28.8%
(26.6, 31.2)
Land ownership
 Did not own land
39
2.6%
(1.9, 3.5)
 Owns land
1462
97.4%
(96.5, 98.1)
As an initial assessment of intervention recall and question comprehension, we assessed the proportion of mothers that responded DK when asked about each intervention or practice at the initial post-birth assessment and at follow-up (Table 2). Only a handful of indicators (4 for facility births, 1 for home births) had a greater than 5% DK response rate during the initial assessment, but this increased to 9 and 5 indicators, respectively, at follow-up. Recall of the type of injection received the highest proportion of DK responses. During the initial interview, most mothers reported receiving multiple injections during delivery, and mothers could not identify approximately 90% of the injections they reportedly received. Recall of type of injection was also poor at the follow-up survey, however it was partially masked by a reduction in the number of injections that mothers reported receiving during delivery. During the initial assessment, women reported receiving 1.83 injections on average, which fell to 1.27 during the follow-up survey.
Table 2
Rate of “don’t know” responses by question, during initial and follow-up interview, by site of delivery
 
Facility Births
Home Births
Initial
Follow-up
Initial
Follow-up
n
% DK
n
% DK
n
% DK
n
% DK
Clean Birth Kit - Any Item Used
691
2.6
693
3.8
808
0
808
0.4
Clean Birth Kit - Sheet Used
691
2.9
693
7.5
808
0.1
808
1.5
Clean Birth Kit - Soap Used
691
7.2
693
8.1
808
0.7
808
2.4
Any injection given during delivery
693
0
683
0
808
0
808
0.2
Type of injection given
1535
90.0
1016
86.2
1220
89.2
896
87.8
Newborn wrapped before placenta delivered
693
2.3
693
13.3
808
0.1
808
7.8
Newborn washed before placenta delivered
693
2.2
693
20.5
808
0
808
9.2
Newborn wiped with cloth before placenta delivered
693
3.3
693
19.6
808
0
808
12.5
Newborn placed on mother’s chest or arms before placenta delivered
693
1.7
693
3.3
808
0.1
808
3.5
Cord cut after placenta delivered
693
4.8
693
19.0
808
0.2
808
5.7
Cord cut with new blade
693
10.4
693
28.7
808
0.2
808
1.6
Anything applied to cord stump immediately after delivery
693
5.3
693
15.4
808
0.1
808
2.5
Type of substance applied to cord immediately after delivery
758
0.3
517
1.2
775
0
780
0.1
Breastfeeding initiated in first hour
693
0.1
693
0.1
808
0.1
808
1.0
The proportion of women who gave DK responses was higher overall among women that delivered at a facility, compared to women who delivered at home, at both the initial and follow-up interview. For example, at the initial assessment, 10.4% of women who delivered at a facility could not report whether a new blade had been used to cut the umbilical cord compared to just 0.2% of women who delivered at home. This was true for other cord care indicators, with 5–10% of facility-delivering mothers reporting DK at the initial assessment increasing to 15–29% reporting DK at the follow-up survey. Indicators involving the timing of wiping, wrapping, bathing, and cord-cutting had > 5% DK responses at follow-up across both home and facility births, but the proportion of DK responses was much higher for facility births.
The reported intervention coverage, percent agreement, and kappa values of each indicator are presented in Table 3, and for facility and home deliveries separately in Table 4. The majority of indicators had a high observed percent agreement, but most kappa values were below 0.4, indicating agreement was primarily due to chance. Among all observations, three indicators showed moderate reliability with kappa values greater than 0.4, including “any part of the clean birthing kit used for the delivery,” “sheet from clean birthing kit used for the delivery,” and “cord cut after placenta delivered.” Only one indicator, “received any injection during delivery,” demonstrated high reliability with a kappa of 0.737. Stratifying by place of delivery, the reliability of maternal report was much lower among women who delivered at a facility. Only 5 out of 14 indicators had greater than 70% agreement among facility deliveries, and none had kappa values above 0.4. Among home deliveries, 11 out of 14 indicators had > 70% agreement, and both use of a clean birthing kit and any injection during delivery had kappa values above 0.4 and 0.6 respectively. Inclusion of DK as a separate response category did not significantly alter the reliability of any indicator, with the exception of “received oxytocin / ergometrine during delivery,” where reliability improved due to the high number of DK responses (see Supplementary Tables 2 & 3).
Table 3
Reliability of maternal report of immediate newborn care indicators
 
Proportion report receiving intervention
Observed Agreement
Expected Agreement
Kappa
K
+ > 0.4
++ > 0.6
Initial
Follow-up
n
%
n
%
n
%
95% CI
%
  
Clean Birth Kit - Any Item Used
1482
71.1
1473
80.9
1456
82.6
(80.5–84.4)
63.7
0.520
+
Clean Birth Kit - Sheet Used
1482
63.2
1473
71.7
1456
75.1
(72.8–77.2)
56.1
0.432
+
Clean Birth Kit - Soap Used
1482
64.0
1473
69.5
1456
69.4
(67.0–71.8)
55.8
0.309
 
Any injection given during delivery
1502
74.4
1500
68.3
1500
89.2
(87.5–90.7)
58.9
0.737
++
Injectable Oxytocin / Ergometrine given during delivery
439
98.6
523
98.8
371
99.7
(98.1–99.9)
99.7
0
 
Newborn wrapped before placenta delivered
1485
50.6
1347
58.9
1335
55.7
(53.0–58.3)
50.1
0.112
 
Newborn washed before placenta delivered
1487
0.2
1286
5.8
1276
94.2
(92.8–95.4)
94.1
0.022
 
Newborn wiped with cloth before placenta delivered
1479
44.9
1265
58.8
1249
57.6
(54.8–60.3)
49.0
0.167
 
Newborn placed on mother’s chest or arms before placenta delivered
1489
21.1
1451
15.6
1439
78.2
(76.0–80.2)
69.7
0.280
 
Cord cut after placenta delivered
1467
64.6
1324
72.3
1301
80.9
(78.6–82.9)
57.9
0.545
+
Cord cut with new blade
1427
68.7
1290
91.7
1244
81.6
(79.3–83.6)
71.8
0.346
 
Anything applied to cord immediately after delivery
1464
94.7
1375
92.8
1350
90.4
(88.7–91.8)
89.0
0.128
 
CHX applied to cord stump immediately after delivery
1462
89.1
1368
91.9
1342
87.1
(85.2–88.8)
83.8
0.206
 
Breastfeeding initiated in first hour
1500
35.4
1493
29.9
1491
64.7
(62.2–67.0)
55.8
0.201
 
Table 4
Reliability of maternal report of immediate newborn care indicators, by site of delivery
 
Proportion report receiving intervention
Observed Agreement
Expected Agreement
Kappa
K
+ > 0.4
++ > 0.6
Initial
Follow-up
n
%
n
%
n
%
95% CI
%
  
Facility Delivery
 Clean Birth Kit - Any Item Used
673
44.0
667
62.2
650
66.8
(63.1–70.3)
48.7
0.352
 
 Clean Birth Kit - Sheet Used
673
41.3
667
54.6
650
67.2
(63.5–70.7)
49.2
0.355
 
 Clean Birth Kit - Soap Used
673
37.7
667
57.1
650
62.9
(59.1–66.6)
48.2
0.284
 
 Any injection given during delivery
693
97.0
693
88.2
693
88.9
(86.3–91.0)
85.9
0.215
 
 Injectable Oxytocin / Ergometrine given during delivery
48
6.2
118
1.7
22
95.4
(70.4–99.5)
95.5
0
 
 Newborn wrapped before placenta delivered
677
62.5
601
71.0
590
60.0
(56.0–63.9)
55.4
0.102
 
 Newborn washed before placenta delivered
678
0.3
551
8.7
541
91.3
(88.6–93.4)
91.0
0.034
 
 Newborn wiped with cloth before placenta delivered
670
63.0
557
72.2
541
56.9
(52.7–61.0)
55.6
0.030
 
 Newborn placed on mother’s chest or arms before placenta delivered
681
43.3
670
27.0
659
60.7
(56.9–64.4)
52.9
0.166
 
 Cord cut after placenta delivered
660
22.3
561
39.6
538
59.3
(55.1–63.4)
55.6
0.082
 
 Cord cut with new blade
621
30.4
494
78.7
449
51.0
(46.4–55.6)
41.7
0.160
 
 Anything applied to cord immediately after delivery
656
93.9
586
86.7
561
84.0
(80.7–86.8)
83.1
0.049
 
 CHX applied to cord stump immediately after delivery
654
82.9
580
85.5
554
77.1
(73.4–80.4)
74.1
0.114
 
 Breastfeeding initiated in first hour
692
43.9
692
40.0
691
60.6
(56.9–64.2)
51.2
0.193
 
Home Delivery
 Clean Birth Kit - Any Item Used
808
93.8
805
96.4
805
95.4
(93.7–96.7)
90.6
0.509
+
 Clean Birth Kit - Sheet Used
808
81.6
805
85.8
805
81.5
(78.7–84.0)
72.6
0.325
 
 Clean Birth Kit - Soap Used
808
85.9
805
79.6
805
74.8
(71.7–77.7)
71.3
0.121
 
 Any injection given during delivery
808
55.0
806
51.2
806
89.5
(87.1–91.4)
50.1
0.789
++
 Injectable Oxytocin / Ergometrine given during delivery
391
0.8
405
1.0
349
100
100
 
 Newborn wrapped before placenta delivered
807
40.6
745
49.1
744
52.2
(48.6–55.7)
50.2
0.040
 
 Newborn washed before placenta delivered
808
0.1
734
3.5
734
96.3
(94.7–97.5)
96.3
0
 
 Newborn wiped with cloth before placenta delivered
808
29.8
707
48.2
707
58.0
(54.3–61.6)
50.7
0.148
 
 Newborn placed on mother’s chest or arms before placenta delivered
807
2.4
780
5.9
779
92.9
(90.9–94.5)
91.9
0.124
 
 Cord cut after placenta delivered
806
99.4
762
96.5
762
96.1
(94.4–97.2)
95.8
0.052
 
 Cord cut with new blade
806
98.1
795
99.9
795
98.9
(97.8–99.4)
98.6
0.180
 
 Anything applied to cord immediately after delivery
807
95.4
788
97.3
788
94.9
(93.2–96.3)
93.1
0.261
 
 CHX applied to cord stump immediately after delivery
807
94.2
787
96.6
787
94.2
(92.3–95.6)
91.5
0.314
 
 Breastfeeding initiated in first hour
807
28.1
800
21.3
799
68.1
(64.8–71.2)
62.4
0.151
 
We assessed associations at the indicator level between underlying intervention coverage or prevalence, based on the initial maternal report (after excluding DKs), and measures of maternal recall reliability. There was a U-shaped association between intervention prevalence and observed percent agreement (Fig. 2). The proportion of women who changed their initial report of each indicator and coverage of each intervention or prevalence of each practice in the population is presented in Supplementary Table 4. We observed an association between underlying intervention coverage and the proportion of women over or under-reporting the intervention at the follow-up interview (Fig. 3). Among both home and facility births, we observed a higher proportion of women changed their initial report of no intervention to received intervention (over-reporting) for interventions that were more common in the population. Conversely, we observed a higher proportion of women changed their initial report of received intervention to did NOT receive the intervention (under-reporting) among interventions that were less common in the population. These associations were stronger among home deliveries than facility deliveries. Underlying intervention prevalence accounted for 83% of the variation in over-reporting and 85% of under-reporting among home births, but only 46 and 43% of over- and under-reporting respectively among facility births. There was no association between underlying intervention prevalence and indicator kappa statistics (data not shown).
We observed no significant differences in percent agreement by binned recall time for any of the four best performing indicators (Fig. 4). Similarly, in the adjusted logistic regression model, we observed a negligible but statistically significant reduction in agreement of report by increasing recall period for most indicators, controlling for child sex, place of delivery, birth complications, parity, maternal age, education, and ethnicity (Tables 5). Mothers had statistically lower odds of reliably reporting 10 of 14 interventions if they delivered in a facility and statistically greater odds of reliably reporting if the baby was wrapped before the placenta delivery if they delivered at a facility. After disaggregating by location of delivery, there was little statistical difference in the reliability of report by recall length among home deliveries (Table 6). There were no clear cross-cutting associations between respondent and birth characteristics and over- or under-reporting overall (see Supplementary Tables 5 & 7) or by site of delivery (see Supplementary Tables 6 & 8).
Table 5
Characteristics associated with the observed agreement of maternal report
Indicator
n
Recall period (in weeks)
Site of delivery (home [ref] vs facility)
Delivery complications (no complication [ref] vs complications)
Child sex (male [ref] vs female)
Parity
Maternal age (in years)
Maternal education (no education [ref] vs any education)
Maternal ethnicity (Madhesi [ref] vs Pahadi)
AOR
95% CI
AOR
95% CI
AOR
95% CI
AOR
95% CI
AOR
95% CI
AOR
95% CI
AOR
95% CI
AOR
95% CI
Clean Birth Kit - Any Item Used
1452
0.998
(0.994–1.002)
0.10
(0.07–0.15)
0.98
(0.69–1.40)
1.16
(0.86–1.57)
0.99
(0.86–1.14)
1.03
(0.98–1.07)
0.99
(0.72–1.37)
0.59
(0.31–1.13)
Clean Birth Kit - Sheet Used
1452
0.997
(0.994–1.001)
0.45
(0.34–0.58)
1.00
(0.72–1.37)
0.94
(0.74–1.20)
0.96
(0.86–1.08)
1.00
(0.97–1.04)
1.04
(0.79–1.38)
0.89
(0.47–1.65)
Clean Birth Kit - Soap Used
1452
0.998
(0.995–1.001)
0.55
(0.43–0.71)
1.13
(0.83–1.54)
0.92
(0.74–1.16)
0.97
(0.87–1.07)
1.02
(0.98–1.05)
1.04
(0.80–1.35)
0.88
(0.49–1.60)
Any injection given
1496
0.999
(0.995–1.004)
0.87
(0.61–1.24)
1.01
(0.65–1.57)
0.80
(0.57–1.11)
1.03
(0.89–1.19)
0.97
(0.93–1.02)
1.24
(0.83–1.85)
1.50
(0.52–4.31)
Injectable Oxytocin / Ergo given*
371
                
Newborn wrapped
1331
0.997
(0.994–1.000)
1.38
(1.09–1.76)
0.81
(0.60–1.10)
1.17
(0.94–1.46)
0.97
(0.88–1.08)
1.00
(0.97–1.04)
1.15
(0.89–1.49)
0.82
(0.45–1.49)
Newborn washed
1222
0.995
(0.988–1.001)
0.34
(0.20–0.58)
0.97
(0.53–1.78)
1.81
(1.10–3.00)
0.97
(0.78–1.20)
0.98
(0.91–1.05)
1.20
(0.68–2.11)
 
Newborn wiped
1245
0.996
(0.993–0.999)
0.97
(0.76–1.24)
0.87
(0.63–1.19)
1.29
(1.02–1.62)
0.96
(0.87–1.07)
1.01
(0.97–1.04)
0.95
(0.72–1.24)
0.98
(0.52–1.83)
Newborn placed on mother’s chest or arms
1435
0.995
(0.992–0.999)
0.12
(0.08–0.16)
0.90
(0.64–1.26)
1.14
(0.86–1.50)
0.90
(0.79–1.02)
1.03
(0.99–1.08)
0.85
(0.63–1.16)
0.78
(0.41–1.48)
Cord cut after placenta delivered
1297
0.995
(0.990–0.999)
0.05
(0.04–0.08)
1.06
(0.72–1.56)
1.02
(0.75–1.41)
1.00
(0.86–1.16)
1.01
(0.96–1.06)
1.23
(0.86–1.76)
2.38
(0.99–5.71)
Cord cut with new blade
1241
0.997
(0.991–1.002)
0.01
(0.01–0.03)
1.03
(0.66–1.59)
0.94
(0.65–1.36)
1.04
(0.87–1.24)
1.00
(0.94–1.06)
0.84
(0.56–1.24)
0.38
(0.16–0.90)
Anything applied to cord
1347
0.994
(0.988–0.999)
0.28
(0.19–0.43)
0.60
(0.39–0.93)
1.15
(0.79–1.68)
0.92
(0.78–1.09)
1.02
(0.97–1.08)
1.24
(0.80–1.92)
0.75
(0.29–1.89)
CHX applied to cord stump
1339
0.99
(0.985–0.995)
0.20
(0.13–0.29)
1.28
(0.82–2.01)
1.05
(0.75–1.48)
1.00
(0.86–1.17)
0.98
(0.94–1.03)
0.82
(0.56–1.20)
0.94
(0.42–2.09)
Breastfeeding in first hour
1487
0.998
(0.995–1.001)
0.71
(0.56–0.90)
1.08
(0.81–1.44)
0.86
(0.69–1.07)
1.05
(0.95–1.16)
0.99
(0.96–1.02)
1.02
(0.79–1.31)
1.47
(0.81–2.66)
* Indicator could not be analyzed due to insufficient variablity in outcome
Table 6
Characteristics associated with the observed agreement of maternal report, by site of delivery
 
n
Recall period (in weeks)
Delivery complications (none [ref] vs complications)
Child sex (male [ref] vs female)
Parity
Maternal age (in years)
Maternal education (no education [ref] vs any education)
Maternal ethnicity (Madhesi [ref] vs Pahadi)
 
AOR
95% CI
AOR
95% CI
AOR
95% CI
AOR
95% CI
AOR
95% CI
AOR
95% CI
AOR
95% CI
Facility Delivery
 Clean Birth Kit - Any Item Used
649
0.997
(0.993–1.002)
1.00
(0.68–1.45)
1.22
(0.87–1.71)
1.00
(0.85–1.17)
1.01
(0.96–1.06)
0.88
(0.62–1.26)
0.54
(0.27–1.08)
 Clean Birth Kit - Sheet Used
649
0.995
(0.990–1.000)
1.01
(0.69–1.46)
1.16
(0.83–1.62)
1.00
(0.85–1.17)
1
(0.95–1.05)
0.95
(0.67–1.36)
0.73
(0.36–1.48)
 Clean Birth Kit - Soap Used
649
0.998
(0.993–1.002)
1.16
(0.80–1.68)
1.07
(0.77–1.48)
0.91
(0.78–1.07)
1.05
(0.99–1.10)
0.89
(0.63–1.26)
0.76
(0.38–1.52)
 Any injection given
692
1.004
(0.997–1.011)
1.44
(0.82–2.55)
0.86
(0.53–1.38)
1.10
(0.89–1.35)
0.94
(0.88–1.00)
1.11
(0.66–1.87)
2.56
(0.59–11.15)
 Injectable Oxytocin / Ergo given*
22
              
 Newborn wrapped
589
0.994
(0.989–0.999)
0.85
(0.58–1.24)
0.97
(0.70–1.36)
1.07
(0.91–1.27)
0.98
(0.93–1.03)
1.11
(0.77–1.60)
0.81
(0.39–1.67)
 Newborn washed
505
0.997
(0.989–1.006)
1.51
(0.71–3.21)
2.41
(1.24–4.69)
0.90
(0.68–1.18)
0.98
(0.89–1.08)
1.90
(0.93–3.92)
 
 Newborn wiped
540
0.994
(0.989–0.999)
0.77
(0.52–1.13)
1.16
(0.82–1.64)
1.01
(0.85–1.20)
1.00
(0.95–1.06)
1.03
(0.70–1.49)
1.15
(0.53–2.51)
 Newborn placed on mother’s chest or arms
658
0.994
(0.989–0.998)
0.94
(0.66–1.35)
1.11
(0.80–1.53)
0.87
(0.74–1.01)
1.02
(0.97–1.07)
0.72
(0.51–1.02)
0.78
(0.39–1.57)
 Cord cut after placenta delivered
537
0.996
(0.991–1.001)
1.02
(0.68–1.54)
1.01
(0.71–1.44)
0.99
(0.84–1.17)
1.00
(0.95–1.06)
1.13
(0.77–1.65)
2.85
(1.12–7.26)
 Cord cut with new blade
448
0.996
(0.991–1.002)
1.04
(0.67–1.63)
0.90
(0.61–1.31)
1.06
(0.88–1.28)
0.99
(0.93–1.06)
0.80
(0.53–1.20)
0.36
(0.14–0.89)
 Anything applied to cord
560
0.996
(0.989–1.003)
0.60
(0.36–0.98)
1.26
(0.79–2.00)
0.98
(0.79–1.22)
1.01
(0.94–1.08)
1.41
(0.84–2.35)
0.60
(0.23–1.61)
 CHX applied to cord stump
553
0.989
(0.983–0.995)
1.40
(0.85–2.30)
1.39
(0.92–2.11)
1.09
(0.89–1.32)
0.97
(0.91–1.03)
0.79
(0.51–1.23)
1.02
(0.42–2.47)
 Breastfeeding in first hour
690
0.998
(0.993–1.002)
1.01
(0.72–1.42)
0.90
(0.66–1.23)
1.07
(0.93–1.24)
0.98
(0.94–1.03)
1.03
(0.74–1.44)
1.43
(0.71–2.90)
Home Delivery
 Clean Birth Kit - Any Item Used
786
1.001
(0.992–1.011)
0.85
(0.29–2.50)
0.96
(0.49–1.87)
0.93
(0.67–1.29)
1.10
(0.98–1.24)
2.10
(0.79–5.61)
 
 Clean Birth Kit - Sheet Used
803
1
(0.995–1.005)
1.03
(0.54–1.95)
0.73
(0.51–1.04)
0.93
(0.79–1.08)
1.01
(0.96–1.07)
1.25
(0.77–2.02)
3.14
(0.41–24.25)
 Clean Birth Kit - Soap Used
803
0.998
(0.994–1.003)
1.02
(0.58–1.81)
0.79
(0.58–1.09)
1.01
(0.88–1.17)
0.99
(0.95–1.04)
1.29
(0.84–1.97)
1.42
(0.40–5.12)
 Any injection given
804
0.996
(0.990–1.002)
0.56
(0.28–1.09)
0.77
(0.49–1.21)
0.97
(0.80–1.19)
1.00
(0.94–1.07)
1.57
(0.82–3.00)
0.65
(0.14–3.02)
 Injectable Oxytocin / Ergo given*
349
              
 Newborn wrapped
742
0.999
(0.994–1.003)
0.77
(0.45–1.30)
1.34
(1.00–1.79)
0.92
(0.80–1.05)
1.02
(0.97–1.06)
1.23
(0.84–1.79)
0.91
(0.32–2.59)
 Newborn washed
717
0.991
(0.980–1.002)
0.32
(0.12–0.84)
1.22
(0.55–2.70)
1.21
(0.82–1.77)
0.95
(0.84–1.06)
0.47
(0.20–1.15)
 
 Newborn wiped
705
0.997
(0.993–1.001)
1.17
(0.67–2.03)
1.40
(1.03–1.89)
0.93
(0.81–1.07)
1.01
(0.97–1.06)
0.88
(0.60–1.30)
0.64
(0.21–1.98)
 Newborn placed on mother’s chest or arms
777
1.001
(0.993–1.009)
0.59
(0.25–1.39)
1.26
(0.72–2.22)
0.95
(0.73–1.24)
1.09
(0.99–1.19)
1.70
(0.79–3.66)
0.78
(0.10–6.31)
 Cord cut after placenta delivered
760
0.991
(0.981–1.001)
1.34
(0.31–5.85)
1.16
(0.55–2.45)
1.02
(0.71–1.45)
1.06
(0.94–1.19)
2.23
(0.73–6.78)
0.42
(0.05–3.56)
 Cord cut with new blade
776
0.998
(0.980–1.017)
0.73
(0.09–6.09)
1.72
(0.42–6.98)
0.84
(0.47–1.50)
1.09
(0.88–1.36)
2.33
(0.28–19.59)
 
 Anything applied to cord
770
0.99
(0.981–0.998)
0.69
(0.26–1.85)
0.97
(0.51–1.85)
0.83
(0.63–1.09)
1.04
(0.95–1.15)
0.96
(0.42–2.21)
 
 CHX applied to cord stump
786
0.992
(0.984–1.000)
1.06
(0.36–3.09)
0.58
(0.32–1.07)
0.86
(0.67–1.11)
1.02
(0.94–1.12)
1.02
(0.46–2.27)
0.89
(0.11–7.32)
 Breastfeeding in first hour
797
0.999
(0.995–1.003)
1.31
(0.75–2.29)
0.82
(0.61–1.11)
1.03
(0.90–1.18)
1.00
(0.96–1.05)
1.01
(0.69–1.48)
1.62
(0.51–5.13)
* Indicator could not be analyzed due to insufficient variability in outcome

Discussion

This study found poor reliability of maternal report of immediate newborn care indicators as collected through a household survey. A high percent agreement between initial and follow-up reports was observed for most interventions. However, the kappa values for most interventions were low, suggesting observed agreement was mostly due to chance from very high or very low intervention coverage. This was further evidenced by the U-shaped association between intervention prevalence and observed agreement. Only receipt of an injection during delivery could be recalled with high reliability, but not information on the type of injection. For most indicators, women who delivered at home had greater odds of reliably reporting on the intervention compared to women who delivered at a facility. We also observed a high proportion of women who delivered in health facilities failing to recall interventions during the initial interview (< 72 h) after delivery. A negligible, although sometimes statistically significant, decline in recall reliability with increasing time since birth was observed for most indicators.
This study reinforces previous research that suggests mothers are unable to effectively recall interventions or practices which occur during the peripartum period. Studies by Blanc, McCarthy, and Stanton have demonstrated poor recall accuracy within the peripartum period among women in multiple low- and middle-income settings [26]. Multiple factors could contribute to poor recall. Our study suggests that mothers may never have known about some interventions they received – as evidenced by the high proportion of mothers that reported they didn’t know the type of injection they received among both facility and home births at the initial assessment. This agrees with findings from Mexico and Kenya, which showed poor recall of peripartum interventions among women at initial discharge from their labor and delivery facility [2, 3]. Similar to previous studies, we found recall close to the time of care was generally poor; however, there was little evidence of reliability-altering recall degradation with increasing time since delivery up to a two-year recall period [5, 6]. Currently, the DHS asks women to report on delivery and newborn care for their most recent birth in the previous 3 years, with surveys prior to Phase 8 asking about births in the previous 5 years. However, this study and others only assessed recall for up to 2 years postpartum.
Previous studies have primarily assessed recall among women who delivered in health facilities. In general, this study found the proportion of women who were unable to report whether they received an intervention within 72 h of birth was higher among facility deliveries relative to home deliveries. A possible explanation is that women delivering in a facility may not have been informed about the details of interventions received, such as the substance applied to the child’s umbilical cord or whether the instrument used to cut the cord was new or had been sterilized. We also observed significantly weaker recall reliability for most indicators among women who delivered at a facility compared to women who delivered at home. This suggests receipt of these interventions were less salient events for women delivering in facilities potentially because they were not informed or counseled on various interventions, events may have been obscured by an unfamiliar or chaotic environment, or they paid less attention to events because they trusted the skilled attendants providing care. Alternatively, mothers may have had a better rapport with home birth attendants, often family or other community members, who may have more effectively communicated events occurring throughout the delivery process. No other characteristics had a consistent effect on mothers’ recall reliability.
We observed an association between underlying intervention coverage and maternal report. Interventions that were more common in the population were more likely to be over-reported during the follow-up interview. Likewise, interventions that were uncommon in the population were more likely to be under-reported. This association was stronger among home births than facility births. A forthcoming assessment of maternal report of antenatal and postnatal care interventions in Kenya, Cambodia, and Bangladesh found a similar association between intervention prevalence and under- and over-reporting of intervention receipt among women receiving facility-based care [8]. This association could potentially reflect a social desirability bias, such as wanting to report a practice the mother thought the interviewer would perceive favorably. Alternatively, if the mother could not clearly recall the intervention, she may assume that an intervention did or did not occur if it was or was not a standard practice in the setting.
This study had a number of limitations. This analysis is limited to assessing the test-retest reliability of maternal report and changes in response over time. We were unable to observe interventions and practices during delivery, so we are unable to assess the validity of maternal report. Our assessment did effectively assess changes in recall over time and demonstrated inconsistencies in women’s reports of interventions received. Another limitation is that women were classified as having delivered at home or in a facility; however, 2.3% of women delivered on the way to a health facility. These women were classified as delivering at home because of the lack of services they would have received in-transit. Less than half (n = 11) of those women reported continuing on to a health facility, so we would expect that categorizing them as home births would have minimal effect on the study findings. Additionally, this study was conducted in a study population that has received a number of interventions related to clean delivery and newborn care over a number of years. This population may have been uniquely primed to recall interventions or may have felt additional pressure to report use of specific interventions. Use of clean delivery kits and clean cord practices was high in this population among both home and facility births due to the trial protocol of providing clean delivery kits and the existence of a successful national chlorhexidine cord care program in Nepal. The reliability of reporting may be different within a population with lower coverage and perhaps less awareness of these interventions. Additional work is needed to assess coverage of interventions among home births in populations without high access to clean birth kits and programs for safer home delivery practices.

Conclusions

This study reinforces previous findings that mothers are unable to effectively report on many interventions or practices within the peripartum period. Household surveys which rely on maternal report therefore may not be an appropriate method for collecting data on coverage of many interventions during the peripartum period. This is particularly true among facility births, where many interventions may occur without the mother’s full knowledge. New methods are needed for generating more robust estimates of peripartum intervention coverage. Data suggest that mothers are able to accurately report on the location on delivery. Linking valid data on where mothers deliver with robust data on the content and quality of delivery care at these facilities may be used to generate estimates of intervention coverage.

Acknowledgements

The authors thank the study team at the Nepal Nutrition Intervention Project–Sarlahi, who conducted the household data collection.
The parent trial and validation substudy were approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board in Baltimore, USA. In Nepal, approval was received from the Tribhuvan University Institute of Medicine, Kathmandu (parent trial) and the Nepal Health Research Council, Kathmandu (substudy). Women under the age of 16 were included in the study if married and provided their own consent in line with Nepal IRB rules. Staff obtained written consent from all participants.
Not applicable.

Competing interests

All authors have completed the ICMJE uniform disclosure form at http://​www.​icmje.​org/​coi_​disclosure.​pdf (available upon request from the corresponding author). Dr. Carter reports grants from Bill & Melinda Gates Foundation, during the conduct of the study. Dr. Chang reports grants from Bill & Melinda Gates Foundation, during the conduct of the study. Dr. Mullany reports grants from Bill & Melinda Gates Foundation, during the conduct of the study; grants from NIH, grants from TRAction / USAID, grants from Bill & Melinda Gates Foundation, outside the submitted work. Dr. Khatry and Mr. LeClerq have nothing to disclose. Dr. Munos reports grants from Bill & Melinda Gates Foundation, during the conduct of the study; grants from Bill & Melinda Gates Foundation, grants from Global Affairs Canada, outside the submitted work. Dr. Katz reports grants from Bill and Melinda Gates Foundation, during the conduct of the study; grants from NIH, grants from Thrasher Fund, grants from Whole New World Foundation, grants from USAID, outside the submitted work.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
2.
Zurück zum Zitat Blanc AK, Diaz C, McCarthy KJ, Berdichevsky K. Measuring progress in maternal and newborn health care in Mexico: validating indicators of health system contact and quality of care. BMC Pregnancy Childbirth. 2016;16(1):255.CrossRef Blanc AK, Diaz C, McCarthy KJ, Berdichevsky K. Measuring progress in maternal and newborn health care in Mexico: validating indicators of health system contact and quality of care. BMC Pregnancy Childbirth. 2016;16(1):255.CrossRef
3.
Zurück zum Zitat Blanc AK, Warren C, McCarthy KJ, Kimani J, Ndwiga C, RamaRao S. Assessing the validity of indicators of the quality of maternal and newborn health care in Kenya. J Glob Health. 2016;6(1):010405.CrossRef Blanc AK, Warren C, McCarthy KJ, Kimani J, Ndwiga C, RamaRao S. Assessing the validity of indicators of the quality of maternal and newborn health care in Kenya. J Glob Health. 2016;6(1):010405.CrossRef
4.
Zurück zum Zitat Stanton CK, Rawlins B, Drake M, dos AM, Cantor D, Chongo L, et al. Measuring coverage in MNCH: testing the validity of Women’s self-report of key maternal and newborn health interventions during the Peripartum period in Mozambique. PLoS One. 2013;8(5):e60694.CrossRef Stanton CK, Rawlins B, Drake M, dos AM, Cantor D, Chongo L, et al. Measuring coverage in MNCH: testing the validity of Women’s self-report of key maternal and newborn health interventions during the Peripartum period in Mozambique. PLoS One. 2013;8(5):e60694.CrossRef
5.
Zurück zum Zitat McCarthy KJ, Blanc AK, Warren CE, Kimani J, Mdawida B, Ndwidga C. Can surveys of women accurately track indicators of maternal and newborn care? A validity and reliability study in Kenya. J Glob Health. 2016;6(2):020502.CrossRef McCarthy KJ, Blanc AK, Warren CE, Kimani J, Mdawida B, Ndwidga C. Can surveys of women accurately track indicators of maternal and newborn care? A validity and reliability study in Kenya. J Glob Health. 2016;6(2):020502.CrossRef
6.
Zurück zum Zitat McCarthy KJ, Blanc AK, Warren CE, Mdawida B. Women’s recall of maternal and newborn interventions received in the postnatal period: a validity study in Kenya and Swaziland. J Glob Health. 2018;8(1):010605.CrossRef McCarthy KJ, Blanc AK, Warren CE, Mdawida B. Women’s recall of maternal and newborn interventions received in the postnatal period: a validity study in Kenya and Swaziland. J Glob Health. 2018;8(1):010605.CrossRef
8.
Zurück zum Zitat McCarthy KJ, Warren C, Bajracharya A, Bellows B, Blanc AK. Validating women’s reports of antenatal and postnatal care received in Bangladesh, Cambodia and Kenya. BMJ Glob Health. 2020;5:e002133.CrossRef McCarthy KJ, Warren C, Bajracharya A, Bellows B, Blanc AK. Validating women’s reports of antenatal and postnatal care received in Bangladesh, Cambodia and Kenya. BMJ Glob Health. 2020;5:e002133.CrossRef
Metadaten
Titel
Reliability of maternal recall of delivery and immediate newborn care indicators in Sarlahi, Nepal
verfasst von
Emily D. Carter
Karen T. Chang
Luke C. Mullany
Subarna K. Khatry
Steven C. LeClerq
Melinda K. Munos
Joanne Katz
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2021
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-021-03547-5

Weitere Artikel der Ausgabe 1/2021

BMC Pregnancy and Childbirth 1/2021 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.